Post-acute COVID-19 syndrome

D Montani, L Savale, N Noel… - European …, 2022 - Eur Respiratory Soc
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the coronavirus disease 2019 (COVID-19) pandemic that has resulted in …

Laboratory biomarkers for diagnosis and prognosis in COVID-19

D Battaglini, M Lopes-Pacheco… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of
clinical manifestations, with progression to multiorgan failure in the most severe cases …

Long-term cardiovascular outcomes of COVID-19

Y Xie, E Xu, B Bowe, Z Al-Aly - Nature medicine, 2022 - nature.com
The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well
described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been …

Long COVID: a review and proposed visualization of the complexity of long COVID

R Perumal, L Shunmugam, K Naidoo… - Frontiers in …, 2023 - frontiersin.org
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus–2 (SARS-CoV-2)
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …

Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines

DK Shay, TT Shimabukuro, F DeStefano - JAMA cardiology, 2021 - jamanetwork.com
Two reports in the current issue of JAMA Cardiology describe cases of acute myocarditis that
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …

Beneficial properties of bromelain

P Hikisz, J Bernasinska-Slomczewska - Nutrients, 2021 - mdpi.com
Bromelain is a major sulfhydryl proteolytic enzyme found in pineapple plants, having
multiple activities in many areas of medicine. Due to its low toxicity, high efficiency, high …

COVID-19 and the vasculature: current aspects and long-term consequences

B Martinez-Salazar, M Holwerda, C Stuedle… - Frontiers in cell and …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …

The pathophysiology of long COVID throughout the renin-angiotensin system

S Khazaal, J Harb, M Rima, C Annweiler, Y Wu, Z Cao… - Molecules, 2022 - mdpi.com
COVID-19 has expanded across the world since its discovery in Wuhan (China) and has
had a significant impact on people's lives and health. Long COVID is a term coined by the …

Association of COVID-19 with comorbidities: An update

S Chatterjee, LV Nalla, M Sharma… - ACS Pharmacology & …, 2023 - ACS Publications
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) which was identified in Wuhan, China in December 2019 and …

Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte

N D'onofrio, L Scisciola, C Sardu, MC Trotta… - Cardiovascular …, 2021 - Springer
Rationale About 50% of hospitalized coronavirus disease 2019 (COVID-19) patients with
diabetes mellitus (DM) developed myocardial damage. The mechanisms of direct SARS …